シード・アーリーステージからのリード投資を中心に、デジタルテクノロジーによる社会の革新や、医療健康などの課題解決に取り組む技術系スタートアップに投資対象を拡げ投資活動を推進しています。
Location: Japan, Minato
Phone: +81 3-6435-0945
Investors 1
| Date | Name | Website |
| - | GREE LP Fu... | greelpfund... |
Mentions in press and media 8
| Date | Title | Description |
| 13.08.2024 | Keio Innovation Initiative (KII) Keio Innovation Initiative “KII No. 3 Impact Fund” final closes at 20.2 b illion yen | Keio Innovation Initiative (KII) Keio Innovation Initiative “KII No. 3 Impact Fund” final closes at 20.2 billion yen ―Promoting impact-orientation and supporting the social implementation of excellent research results― …… The Keio Innovatio... |
| 03.06.2024 | Keio Innovation Initiative (KII) KII invests in Space Quarters, which provides architectural services in outer space | Keio Innovation Initiative (KII) KII invests in Space Quarters, which provides architectural services in outer space Developing a space architecture system to construct large structures that serve as infrastructure in orbit and on the lunar... |
| 03.06.2024 | Keio Innovation Initiative (KII) KII invests in Corvato Health, which develops AI that supports diagnosis of heart disease | Keio Innovation Initiative (KII) KII invests in Colbat Health, which develops AI that supports diagnosis of heart disease KII invests in Colbat Health, which develops AI that supports diagnosis of heart disease …… Keio Innovation Initiative... |
| 07.05.2024 | Keio Innovation Initiative (KII) KII invests in PURMX Therapeutics, which develops innovative anti-cancer drugs using natural microRNA. | Keio Innovation Initiative (KII) KII invests in PURMX Therapeutics, which develops innovative anti-cancer drugs using natural microRNA Accelerate global clinical trials and new pipeline development for MIRX002 …… Keio Innovation Initiative ... |
| 23.04.2024 | Keio Innovation Initiative (KII) KII invests in Red Arrow Therapeutics, which develops next-generation anticancer drugs using nanotechnology | Keio Innovation Initiative (KII) KII invests in Red Arrow Therapeutics, which develops next-generation anticancer drugs using nanotechnology Promoting the development and manufacturing of anticancer drugs using innovative drug delivery tech... |
| 18.10.2023 | KIIが視触覚センシング技術の社会実装を実現するFingerVisionに追加出資 | 慶應イノベーション・イニシアティブ（KII）は、大学の研究成果に基づいた高度な視触覚センシング技術を実用化して、食品業界のDX化を促進するFingerVisionに対して追加出資をいたしました。FingerVisionは今回の増資により総額4.1億円の資金調達を実施し、経営及び開発体制を強化し、食品業界向けDXソリューション等の実用化を加速させて参ります。 慶應イノベーション・イニシアティブ（本社：東京都港区、代表取締役社長 山岸広太郎、以下KII）は、弊社が運営するファン... |
| 30.07.2021 | Стартапы Японии и Китая: самые успешные стартапы 2021 года | Стартапы Японии и Китая: самые успешные стартапы 2021 года |
| 08.02.2017 | Japan: Digital health venture CureApp closes $3.4m | Premium Japan’s digital health startup CureApp announced on Monday that it has raised 380 million yen ($3.4 million) from existing investor Beyond Next Ventures, and new investors Keio Innovation Initiative and SBI Investment. Continue read... |